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The genome-wide mapping presented in this issue by Rahl et al. (2010) demonstrates how the 
transcription factor c-Myc interfaces with the machinery that controls RNA polymerase II elonga-
tion. These findings account for the ability of c-Myc to activate the expression of a large number 
of genes that promote rapid proliferation.How the pattern of gene expression in 
an individual cell type is established is a 
crucial question that has been extensively 
studied for over three decades. A combi-
nation of genetics and in vitro biochemis-
try led to the discovery of factors that are 
required for or influence initiation, elonga-
tion, and termination by RNA polymerase II 
(Pol II). More recently, mapping the binding 
of Pol II and its associated factors across 
the genomes of human, mouse, and the 
fruit fly Drosophila has provided a more 
global view of these events. Together, 
these studies refute the view that gene 
expression is controlled mainly by the 
selective initiation of transcription. Instead, 
most genes experience initiation, but only 
specific genes produce mRNAs. The ele-
gant study by Rahl et al. (2010) in this issue 
clearly demonstrates that regulation of the 
elongation phase of transcription plays a 
major role in gene expression in mouse 
embryonic stem (ES) cells.
In 1992, a model for the control of Pol 
II elongation was proposed that incor-
porated both negative factors that trap 
engaged polymerases in promoter-prox-
imal positions and positive factors that 
selectively promote productive elongation 
(Marshall and Price, 1992). Since then, 
specific positive and negative factors 
have been identified (Nechaev and Adel-
man, 2008). As indicated in Figure 1, two 
negative factors, DRB-sensitivity induc-
ing factor (DSIF) and negative elongation 
factor (NELF), associate with the elonga-
tion complex and help to pause Pol II in 
a position proximal to promoters. Positive 
transcription elongation factor b (P-TEFb) 
phosphorylates the negative factors and 
Pol II, which causes the elongation com-plex to enter productive elongation. At the 
heart of this model are the paused poly-
merases that are poised for activation.
Although poised polymerases were 
initially discovered on a number of spe-
cific genes (Nechaev and Adelman, 
2008), evidence is mounting that they 
are prevalent across mammalian and 
fruit fly genomes. Using a combination 
of chromatin immunoprecipitation and 
microarray analysis (ChIP-chip), large 
peaks of Pol II have been mapped to 
promoter-proximal regions in Drosophila 
and humans (Guenther et al., 2007; Muse 
et al., 2007; Zeitlinger et al., 2007). The 
study by Rahl and colleagues extends 
this using chromatin immunoprecipita-
tion followed by sequencing (ChIP-seq) 
to map the location of Pol II, DSIF, and 
NELF in mouse ES cells. They find that 
most genes have Pol II in promoter-
proximal positions and that both DSIF 
and NELF map to the same locations, 
consistent with the notion that these 
polymerases are engaged in transcrip-Cell 1tion. DSIF, but not NELF, maps with Pol 
II at highly transcribed genes and down-
stream of their poly(A) sites.
The results described by Rahl et al. 
provide strong evidence that activa-
tion of transcription is accomplished at 
least in part at the level of elongation. 
First, they show that P-TEFb is generally 
required for transcription of mRNAs by 
performing Pol II ChIP-seq on mouse ES 
cells treated with the P-TEFb inhibitor fla-
vopiridol. Following treatment only poised 
polymerases remained. They confirm that 
P-TEFb interacts with c-Myc in mouse ES 
cells and then show that almost all genes 
targeted by c-Myc experience elongation 
(Figure 1). Finally, they find that treatment 
of cells with a compound that inhibits 
c-Myc function and reduces the expres-
sion of mRNAs induced by c-Myc causes 
a reduction in elongation but does not 
affect polymerase pausing at the affected 
genes. Inhibition of c-Myc mimics fla-
vopiridol treatment on the c-Myc-induced 
genes. In contrast, reduction of Oct4, a Figure 1. c-Myc Controls RNA Polymerase II Elongation
After initiation, RNA polymerase II (Pol II) pauses in a promoter-proximal position due to the action of 
DSIF and NELF. These polymerases are located on most genes and are poised for entry into productive 
elongation that is triggered by the phosphorylation of DSIF and NELF as well as the C-terminal domain 
(CTD) of Pol II by P-TEFb. c-Myc bound to nearby DNA recruits P-TEFb to function on a large subset of 
genes in mouse embryonic stem cells.41, April 30, 2010 ©2010 Elsevier Inc. 399
transcription factor important for mouse 
ES cells, does not have the same effect 
on Oct4-induced genes. Instead, in that 
case, the presence of poised and elon-
gating Pol II are both reduced.
In the larger context, poised polymerase 
appears to be one of the major features of 
higher eukaryotic genomes, and how it is 
employed is now becoming clear. Although 
there was some reluctance to believe that 
genomes were loaded with engaged poly-
merases that were not elongating for the 
most part, strong evidence in support of 
this notion has come from the sequencing 
of nascent human and Drosophila RNAs 
(Core et al., 2008; Nechaev et al., 2010) 
and from studies showing association 
of elongation factors with the poised Pol 
II (Gilchrist et al., 2008; Rahl et al., 2010). 
Extensive analysis of the heat shock 
genes in Drosophila by the lab of John 
Lis implicates poised polymerase in rapid 
gene activation (Nechaev and Adelman, 
2008). In Drosophila, poised polymerases 
allow synchronous rather than stochastic 
expression of genes induced during devel-
opment (Boettiger and Levine, 2009). Inter-
estingly, when NELF is knocked down in 
Drosophila it causes a reduction or loss of 400 Cell 141, April 30, 2010 ©2010 Elsevier I
The variable domains of antigen recep-
tors are encoded by exons assembled 
during B and T lymphocyte development 
from component V, D, and J gene seg-
ments. This assembly process, called 
V(D)J recombination, depends on a series 
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V(D)J recombination of antigen 
lymphoid-specific proteins RAG
RAG2 use DNA sequence specifi
for V(D)J recombination at differethe poised Pol II on some genes, and this 
leads to reduced gene expression and a 
reduction in initiation (Gilchrist et al., 2008). 
Evidently, the poised Pol II is needed to 
hold some promoters in an open state. In 
the Rahl et al. study knockdown of NELF 
has a similar although more modest effect 
on the distribution of Pol II. By comparison, 
knockdown of DSIF leads to a more dra-
matic increase in Pol II downstream of the 
promoters of actively transcribed genes.
It is now time to attain a better under-
standing of the mechanisms involved 
in generating poised Pol II and how it 
is released into productive elongation. 
Although it is likely that some factors 
involved in generating poised poly-
merases remain to be discovered, there 
is already an abundance of evidence 
pointing toward selective utilization of 
P-TEFb as the key to achieving gene-
specific activation. As demonstrated 
by Rahl et al., recruitment of P-TEFb is 
strongly implicated in c-Myc function. 
Looking to the future, it may be possible 
to develop compounds targeting the step 
in transcriptional elongation regulated by 
c-Myc/P-TEFb that might be effective in 
halting the proliferation of cancer cells.nc.
of site-specific DNA recombination reac-
tions and is orchestrated by the RAG1 and 
RAG2 proteins, which are coexpressed 
exclusively by lymphoid cells. RAG1 and 
RAG2 recognize the rearranging V, D, and 
J gene segments and initiate recombina-
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